Active Ingredient
Benzocaine 20%
The following Structured Product Label (SPL) was submitted to the FDA by Dental Technologies, Inc. for the product Alpha-caine (NDC 55346-2901). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, methemoglobinemia warning, allergy alert:, sore throat warning:, do not use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Benzocaine 20%
Oral Anesthetic
For the temporary relief of occasional minor irritation and pain, associated with:
For external use only
Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops:
Do not use if you have a history of allergy to any “caine” anesthetics, such as benzocaine, butacaine, procaine or tetracaine.
If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting consult a doctor promptly. If sore mouth symptoms do not improve in 7 days, see your dentist or doctor promptly.
avoid contact with eyes
ask a health professional before use.
In case of overdose, get medical help or contact Poison Control Center right away.
do not exceed recommended dosage.
Store at 59° to 86° F (15° to 30° C)
Blue 1*, flavor, PEG-8, PEG-75, Red 3*, Red 33*, Red 40*, sodium saccharin, Yellow 10*
*contains one or more of these ingredients.
1-800-835-0885 or 1-847-677-5500 M-F 8:00 a.m. – 4:30 p.m. CST.
Visit www.dentaltech.com
* Please review the disclaimer below.